Bile pigment pharmacokinetics and absorption in the rat: Therapeutic potential for enteral administration

British Journal of Pharmacology

Volumn 164, Issue 7, 2011, Pages 1857-1870

  Bulmer, A C ^a,b,c   Coombes, J S ^b   Blanchfield, J T ^b   Toth, I ^b   Fassett, R G ^b,d   Taylor, S M ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Biopharma Pty Ltd   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

administration; antioxidant; bile pigment; excretion; half life; inflammation; kinetics; metabolism; oxidative stress

Indexed keywords

BILIRUBIN DERIVATIVE; BILIRUBIN DITAURATE; SODIUM BILIRUBINATE; SODIUM BILIVERDINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ADMINISTRATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; ENTERAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ABSORPTION; ANIMALS; BILE; BILIRUBIN; BILIVERDINE; BIOLOGICAL AVAILABILITY; DUODENUM; GASTROINTESTINAL CONTENTS; INJECTIONS; INTESTINES; MALE; PERITONEAL CAVITY; RATS; RATS, WISTAR; TAURINE;

EID: 81355143343     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01413.x     Document Type: Article

References (62)

1. Alonso EM, Whitington PF, Whitington SH, Rivard WA, Given G, (1991). Enterohepatic circulation of nonconjugated bilirubin in rats fed with human milk. J Pediatr 118: 425-430.
2. Barber BJ, Schultz TJ, Randlett DL, (1990). Comparative analysis of protein content in rat mesenteric tissue, peritoneal fluid, and plasma. Am J Physiol 258: G714-G718. (Pubitemid 20180203)
3. Barrowman JA, Bonnett R, Bray PJ, (1976). Metabolism of biliverdin. Biliary excretion of bile pigments after intravenous injection of biliverdin isomers. Biochim Biophys Acta 444: 333-337.
4. Berberat PO, A-Rahim YI, Yamashita K, Warny MM, Csizmadia E, Robson SC, et al,. (2005). Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis. Inflamm Bowel Dis 11: 350-359. (Pubitemid 40542266)
5. Berk PD, Howe RB, Bloomer JR, Berlin NI, (1969). Studies of bilirubin kinetics in normal adults. J Clin Invest 48: 2176-2190.
6. Bernhard K, Ritzel G, Steiner KU, (1954). The biological importance of bile pigments. Bilirubin and biliverdin as antioxidants for vitamin A and essential fatty acids. Helv Chim Acta 37: 306-313.
7. Boiadjiev SE, Watters K, Wolf S, Lai BN, Welch WH, McDonagh AF, et al,. (2004). pKa and aggregation of bilirubin: titrimetric and ultracentrifugation studies on water-soluble pegylated conjugates of bilirubin and fatty acids. Biochemistry 43: 15617-15632. (Pubitemid 39647488)
8. Bonnett R, Davies JE, Hursthouse MB, (1976). Structure of bilirubin. Nature 262: 327-328.
9. Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, et al,. (1999). Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 116: 1420-1427. (Pubitemid 29258891)
10. Brodersen R, (1979). Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem 254: 2364-2369. (Pubitemid 9160050)
11. Bulmer AC, Blanchfield JT, Coombes JS, Toth I, (2008a). In vitro permeability and stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg Med Chem 16: 3616-3625. (Pubitemid 351484046)
12. Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS, (2008b). Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis 199: 390-396.
13. Bulmer AC, Ried K, Wagner K-H, (2008c). The anti-mutagenic properties of bile pigments. Mutat Res 658: 28-41. (Pubitemid 351172879)
14. Ceran C, Sonmez K, Turkyllmaz Z, Demirogullarl B, Dursun A, Duzgun E, et al,. (2001). Effect of bilirubin in ischemia/reperfusion injury on rat small intestine. J Pediatr Surg 36: 1764-1767. (Pubitemid 33131679)
15. Cohen S, Freeman T, McFarlane A, (1961). Metabolism of I-131-labelled human albumin. Clin Sci 20: 161-170.
16. Frei B, Stocker R, Ames BN, (1988). Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 85: 9748-9752. (Pubitemid 19027202)
17. Gartner LM, Lee KS, Moscioni AD, (1983). Effect of milk feeding on intestinal bilirubin absorption in the rat. J Pediatr 103: 464-471. (Pubitemid 13000470)
18. Gartner U, Goeser T, Wolkoff AW, (1997). Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 113: 1707-1713. (Pubitemid 27461260)
19. Gollan J, Hammaker L, Licko V, Schmid R, (1981). Bilirubin kinetics in intact rats and isolated perfused liver. Evidence for hepatic deconjugation of bilirubin glucuronides. J Clin Invest 67: 1003-1015. (Pubitemid 11090538)
20. Gollan JL, McDonagh AF, Schmidt R, (1977). Biliverdin IX alpha: a new probe of hepatic bilirubin metabolism. Gastroenterology 72: 1186.
21. Gourley GR, Mogilevsky W, Arend RA, Siegel FL, Odell GB, (1985). Effects of anesthetic agents on bile pigment excretion in the rat. Hepatology 5: 610-614. (Pubitemid 15029732)
22. Hahm JS, Ostrow JD, Mukerjee P, Celic L, (1992). Ionization and self-association of unconjugated bilirubin, determined by rapid solvent partition from chloroform, with further studies of bilirubin solubility. J Lipid Res 33: 1123-1137.
23. Hammerman C, Goldschmidt D, Caplan MS, Kaplan M, Bromiker R, Eidelman AI, et al,. (2002). Protective effect of bilirubin in ischemia-reperfusion injury in the rat intestine. J Pediatr Gastroenterol Nutr 35: 344-349.
24. Howe RB, Berk PD, Bloomer JR, Berlin NI, (1970). Preparation and properties of specifically labeled radiochemically stable 3H-bilirubin. J Lab Clin Med 75: 499-502.
25. Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, et al,. (2000). Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol 35: 659-664.
26. Kotal P, Vitek L, Fevery J, (1996). Fasting-related hyperbilirubinemia in rats: the effect of decreased intestinal motility. Gastroenterology 111: 217-223. (Pubitemid 26226902)
27. Lester R, (1963). Intestinal absorption of bilirubin. Ann N Y Acad Sci 111: 290-294.
28. Lester R, Klein PD, (1966). Bile pigment excretion: a comparison of the biliary excretion of bilirubin and bilirubin derivatives. J Clin Invest 45: 1839-1846.
29. Lester R, Schmidt R, (1963a). Intestinal absorption of bile pigments I: the enterohepatic circulation of bilirubin in the rat. J Clin Invest 42: 736-746.
30. Lester R, Schmidt R, (1963b). Intestinal absorption of bile pigments II: bilirubin absorption in man. N Engl J Med 269: 178-182.
31. Lester R, Ostrow JD, Schmid R, (1961). Enterohepatic circulation of bilirubin. Nature 192: 372.
32. Lightner DA, Holmes DL, McDonagh AF, (1996). On the acid dissociation constants of bilirubin and biliverdin. pKa values from 13C NMR spectroscopy. J Biol Chem 271: 2397-2405.
33. McCarty MF, (2007). 'Iatrogenic Gilbert syndrome'-a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypotheses 69: 974-994. (Pubitemid 47430241)
34. McDonagh AF, (1979). Bile pigments: bilatrienes and 5,15-biladienes. In:, Dolphin D, (ed.). The Porphyrins, Vol. VI. Academic Press: New York.
35. McDonagh AF, Lightner DA, Kar AK, Norona WS, (2002). Hepatobiliary excretion of biliverdin isomers and C10-substituted biliverdins in Mrp2-deficient (TR(-)) rats. Biochem Biophys Res Commun 293: 1077-1083. (Pubitemid 34694152)
36. McGeary RP, Szyczew AJ, Toth I, (2003). Biological properties and therapeutic potential of bilirubin. Mini Rev Med Chem 3: 253-256.
37. Mora ME, Bari SE, Awruch J, Delfino JM, (2003). On how the conformation of biliverdins influences their reduction to bilirubins: a biological and molecular modeling study. Bioorg Med Chem 11: 4661-4672. (Pubitemid 37194271)
38. Mukerjee P, Ostrow JD, Tiribelli C, (2002). Low solubility of unconjugated bilirubin in dimethylsulfoxide-water systems: implications for pKa determinations. BMC Biochem 3: 17.
39. Muraca M, Blanckaert N, (1983). Liquid-chromatographic assay and identification of mono- and diester conjugates of bilirubin in normal serum. Clin Chem 29: 1767-1771. (Pubitemid 13017237)
40. Nakagami T, Toyomura K, Kinoshita T, Morisawa S, (1993). A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158: 189-193. (Pubitemid 23291461)
41. Nakama T, Furusawa T, Itoh H, Hisadome T, (1979). Correlation of cholesterol and bilirubin solubilization in bile salt solution. Gastroenterol Jpn 6: 565-572. (Pubitemid 10121268)
42. Nakao A, Otterbein LE, Overhaus M, Sarady JK, Tsung A, Kimizuka K, et al,. (2004). Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 127: 595-606. (Pubitemid 39091907)
43. Ostrow JD, (1986). Bile Pigments and Jaundice, Vol. IV. Marcel Dekker, Inc.: New York.
44. Ostrow JD, Mukerjee P, (2007). Revalidation and rationale for high pKa values of unconjugated bilirubin. BMC Biochem 8: 7.
45. Ostrow JD, Celic L, Mukerjee P, (1988). Molecular and micellar associations in the pH-dependent stable and metastable dissolution of unconjugated bilirubin by bile salts. J Lipid Res 29: 335-348.
46. Otterbein LE, Soares MP, Yamashita K, Bach FH, (2003). Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455. (Pubitemid 36928103)
47. Overhaus M, Moore BA, Barbato JE, Behrendt FF, Doering JG, Bauer AJ, (2006). Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 290: G695-G703.
48. Owens D, Jones EA, Carson ER, (1977). Studies on the kinetics of unconjugated [14C]bilirubin metabolism in normal subjects and patients with compensated cirrhosis. Clin Sci Mol Med 52: 555-570. (Pubitemid 8131034)
49. Rege RV, Webster CC, Ostrow JD, (1988). Interactions of unconjugated bilirubin with bile salts. J Lipid Res 29: 1289-1296. (Pubitemid 18261052)
50. Rice AC, Shapiro SM, (2006). Biliverdin-induced brainstem auditory evoked potential abnormalities in the jaundiced Gunn rat. Brain Res 1107: 215-221. (Pubitemid 44205127)
51. Rothuizen J, van den Brom WE, Fevery J, (1992). The origins and kinetics of bilirubin in healthy dogs, in comparison with man. J Hepatol 15: 25-34.
52. Scott JR, Chin BY, Bilban MH, Otterbein LE, (2007). Restoring HOmeostasis: is heme oxygenase-1 ready for the clinic? Trends Pharmacol Sci 28: 200-205. (Pubitemid 46661005)
53. Spivak W, Carey MC, (1985). Reverse-phase HPLC separation, quantification and preparation of bilirubin and its conjugates from native bile. Quantitative analysis of the intact tetrapyrroles based on HPLC of their ethyl anthranilate azo derivatives. Biochem J 225: 787-805. (Pubitemid 15174267)
54. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN, (1987). Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046. (Pubitemid 17049750)
55. Vitek L, Carey MC, (2003). Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life. Eur J Clin Invest 33: 799-810. (Pubitemid 37082867)
56. Vitek L, Kotal P, Jirsa M, Malina J, Cerna M, Chmelar D, et al,. (2000). Intestinal colonization leading to fecal urobilinoid excretion may play a role in the pathogenesis of neonatal jaundice. J Pediatr Gastroenterol Nutr 30: 294-298. (Pubitemid 30366837)
57. Vitek L, Muchova L, Zelenka J, Zadinova M, Malina J, (2005). The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr 40: 135-140. (Pubitemid 40269731)
58. Vitek L, Majer F, Muchova L, Zelenka J, Jiraskova A, Branny P, et al,. (2006). Identification of bilirubin reduction products formed by Clostridium perfringens isolated from human neonatal fecal flora. J Chromatogr B Analyt Technol Biomed Life Sci 833: 149-157.
59. Wang WW, Smith DL, Zucker SD, (2004). Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 40: 424-433. (Pubitemid 39062860)
60. Wosiewitz U, Schroebler S, (1979). Solubilization of unconjugated bilirubin by bile salts. Experientia 35: 717-718. (Pubitemid 9193859)
61. Zucker SD, Goessling W, Gollan JL, (1995). Kinetics of bilirubin transfer between serum albumin and membrane vesicles. Insight into the mechanism of organic anion delivery to the hepatocyte plasma membrane. J Biol Chem 270: 1074-1081.
62. Zucker SD, Goessling W, Hoppin AG, (1999). Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 274: 10852-10862. (Pubitemid 29191067)